Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MuscleCare is a topical analgesic formulation designed for the management of musculoskeletal pain, specifically targeting conditions like myofascial pain syndrome and trapezius trigger points. Developed as an all-natural alternative to traditional non-steroidal anti-inflammatory drug (NSAID) topicals, it typically combines active counter-irritants such as menthol and camphor with supportive ingredients like methylsulfonylmethane (MSM), glucosamine, and chondroitin. The mechanism of action involves the stimulation of sensory receptors (TRPM8 and TRPV1) to provide a cooling or warming sensation that masks deeper pain signals, while ingredients like MSM may offer localized anti-inflammatory benefits. It has been evaluated in clinical trials against standard treatments like diclofenac (Voltaren) for efficacy in relieving trigger point pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MuscleCare.